Chen et al. (18) |
21 |
Severe: 36.4 / NA Moderate: 10 / NA |
Severe: 2.6 (0.6 to 18.7) Moderate: 0.3 (0.3 to 0.4) |
Severe: 14.3 (13.6 to 14.6) Moderate: 13.4 (12.8 to 13.7) |
Severe: 157 (134 to 184.5) Moderate: 175.6 (148.3 to 194) |
Fraissé et al. (24) |
92 |
TEV: 62 / 3 No TEV: 65 / 14 |
With TEV: 4.4 (1.8 to 2) Without TEV: 2.2 (1.2 to 5.9) |
NA |
NA |
Guan et al. (10) |
1.099 |
Severe: 23.7 / 5.8 Nonsevere: 13.4 / 1.8 |
NA |
NA |
Severe: 137.5 (99 to 179)ϕ Nonsevere: 172 (139 to 212)ϕ
|
Guo et al. (25) |
187 |
Normal TnT: 20.7 / 3 Elevated TnT: 63.5 / 48.3 |
Normal TnT: 0.29 (0.17 to 0.6) Elevated TnT: 3.85 (0.51 to 25.28) |
Normal TnT: 12.4 (12 to 13) Elevated TnT: 13.3 (12.2 to 15.3) |
NA |
Han et al. (26) |
94 |
NA |
Severe: 19.1 Nonsevere: 2.1 |
Severe: 12.7 Nonsevere: 12.2 |
NA |
Huang et al. (21) |
41 |
ICU: 15 / 23 Non-ICU: 14 / 11 |
ICU: 2.4 (0.6 to 14.4) Non-ICU: 0.5 (0.3 to 0.8) |
ICU: 12.2 (11.2 to 13.4) Non-ICU: 10.7 (9.8 to 12.1) |
ICU: 196.0 (165 to 263) Non-ICU: 149.0 (131 to 263) |
Khamis et al. (27) |
63 |
ICU: 29 / 8.3 Non-ICU: 33 / 5.1 |
ICU: 2.3 (0.7 to 4.3) Non-ICU: 0.4 (0.2 to 0.7) |
NA |
ICU: 253 (213 to 322) Non-ICU: 215 (169 to 264) |
Liu et al. (28) |
78 |
Progression: 9 / NA Improvement/stabilization: 18.2 / NA |
Progression: 0.56 (0.21 to 6.84)* Improvement/stabilization: 0.39 (0.2 to 1.07)* |
NA |
Progression: 143.9 (64.81†) Improvement/stabilization: 173.2 (55.37†) |
Pan et al. (29) |
124 |
Discharge: 42.9 / 17.1 Nonsurvivor: 52.8 / 14.6 |
Discharge: 1.12 (0.43 to 5.42) Nonsurvivor: 3.97 (0.78 to 8) |
NA |
Discharge: 197 (143 to 234) Nonsurvivor: 182 (151 to 229) |
Ren et al. (30) |
48 |
All: 39.6 / 22.9 |
All: 3.48 (0.83 to 9.23) |
NA |
NA |
Suleyman et al. (31) |
355 |
ICU: 78.7 / 35 Non-ICU: 68.7 / 24.8 |
ICU: 1.43 (0.81 to 3.22) Non-ICU: 0.95 (0.57 to 1.57) |
NA |
NA |
Tang et al. (32) |
183 |
NA |
Nonsurvivor: 2.1 (0.8 to 5.3) Survivor: 0.6 (0.4 to 1.3) |
Nonsurvivor: 15.5 (14.4 to 16.3) Survivor: 13.6 (13 to 14) |
NA |
Wang et al. (19) |
65 |
NA |
Mild: 1.6 (3†) Severe: 4.7 (7.4†) Extremely severe: 6.9 (8.4†) |
NA |
NA |
Wang et al. (23) |
138 |
ICU: 58.3 / 25.0 No ICU: 21.6 / 10.8 |
ICU: 414 (191 to 1324) Non-ICU: 166 (101 to 285) |
ICU: 13.2 (12.3 to 14.5) Non-ICU: 12.9 (12.3 to 13.4) |
ICU: 142 (119 to 202) Non-ICU: 165 (125 to 188) |
Wu et al. (33) |
201 |
Nonsurvivor: 36.4 / 9.1 Survivor: 17.5 / 2.5 |
Nonsurvivor: 3.95 (1.15 to 10.96) Survivor: 0.49 (0.31 to 1.18) |
Nonsurvivor: 11.6 (11.1 to 12.45) Survivor: 11.75 (10.95 to 12.45) |
Nonsurvivor: 162 (110.5 to 231) Survivor: 204 (137.25 to 262.75) |
Yang et al. (34) |
52 |
Nonsurvivor: NA / 9 Survivor: NA / 10 |
NA |
Nonsurvivor: 12.9 (2.9) Survivor: 10.9 (2.7) |
Nonsurvivor: 191 (74†) Survivor: 164 (63†) |
Zhang et al. (35) |
143 |
DVT: 42.2 / 13.6 Non-DVT: 36.4 / 10.4 |
DVT: 6.6 (2.5 to 8) Non-DVT: 0.9 (0.4 to 3.5) |
DVT: 14.2 (13.3 to 15.4) Non-DVT: 12.9 (12.3 to 14) |
DVT: 185.5 (140.3 to 289) Non-DVT: 229 (170.5 to 285.8) |
Zhou et al. (20) |
191 |
Nonsurvivor: 48 / 24 Survivor: 23 / 1 |
Nonsurvivor: 5.2 (1.5 to 21.1) Survivor: 0.6 (0.3 to 1.0) |
Nonsurvivor: 12.1 (11.2 to 13.7) Survivor: 11.4 (10.4 to 12.6) |
Nonsurvivor: 0.6 (0.5 to 0.8) Survivor: 1.1 (0.8 to 1.5) |